468 related articles for article (PubMed ID: 1406859)
21. [Italian Study on Atrial Fibrillation (SIFA): status report].
Amabile G; Matteoli S; Fattapposta F; Lavezzari M; Trappolini M; Heiman F; Morocutti C
Cardiologia; 1993 Dec; 38(12 Suppl 1):327-32. PubMed ID: 8020032
[TBL] [Abstract][Full Text] [Related]
22. [Atrial fibrillation: anticoagulants or not?].
Zimmermann M
Schweiz Med Wochenschr; 1994 Sep; 124(35):1560-5. PubMed ID: 7939523
[TBL] [Abstract][Full Text] [Related]
23. The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators.
Lancaster TR; Singer DE; Sheehan MA; Oertel LB; Maraventano SW; Hughes RA; Kistler JP
Arch Intern Med; 1991 Oct; 151(10):1944-9. PubMed ID: 1929681
[TBL] [Abstract][Full Text] [Related]
24. Thromboembolic prophylaxis in nonrheumatic atrial fibrillation: utilization patterns, efficacy, and complications in a long-term follow-up of community patients.
Blich M; Gross B
Int J Cardiol; 2004 Jul; 96(1):89-95. PubMed ID: 15203266
[TBL] [Abstract][Full Text] [Related]
25. Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years.
Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
J Am Coll Cardiol; 2009 Sep; 54(11):999-1002. PubMed ID: 19729116
[TBL] [Abstract][Full Text] [Related]
26. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.
Ezekowitz MD; James KE; Nazarian SM; Davenport J; Broderick JP; Gupta SR; Thadani V; Meyer ML; Bridgers SL
Circulation; 1995 Oct; 92(8):2178-82. PubMed ID: 7554199
[TBL] [Abstract][Full Text] [Related]
27. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.
Chimowitz MI; Lynn MJ; Howlett-Smith H; Stern BJ; Hertzberg VS; Frankel MR; Levine SR; Chaturvedi S; Kasner SE; Benesch CG; Sila CA; Jovin TG; Romano JG;
N Engl J Med; 2005 Mar; 352(13):1305-16. PubMed ID: 15800226
[TBL] [Abstract][Full Text] [Related]
28. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH;
Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319
[TBL] [Abstract][Full Text] [Related]
29. The effect of warfarin on mortality and reinfarction after myocardial infarction.
Smith P; Arnesen H; Holme I
N Engl J Med; 1990 Jul; 323(3):147-52. PubMed ID: 2194126
[TBL] [Abstract][Full Text] [Related]
30. Preventing stroke in people with atrial fibrillation: a cross-sectional study.
de Lusignan S; van Vlymen J; Hague N; Thana L; Dzregah B; Chan T
J Public Health (Oxf); 2005 Mar; 27(1):85-92. PubMed ID: 15590708
[TBL] [Abstract][Full Text] [Related]
31. Stroke prevention in atrial fibrillation: pooled analysis of SPORTIF III and V trials.
Albers GW;
Am J Manag Care; 2004 Dec; 10(14 Suppl):S462-9; discussion S469-73. PubMed ID: 15696910
[TBL] [Abstract][Full Text] [Related]
32. Stroke Prevention in Atrial Fibrillation Study. Final results.
Circulation; 1991 Aug; 84(2):527-39. PubMed ID: 1860198
[TBL] [Abstract][Full Text] [Related]
33. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study.
Stroke Prevention in Atrial Fibrillation Study Group Investigators
N Engl J Med; 1990 Mar; 322(12):863-8. PubMed ID: 2407959
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.
Arch Intern Med; 1994 Jul; 154(13):1449-57. PubMed ID: 8018000
[TBL] [Abstract][Full Text] [Related]
35. Pravastatin therapy and the risk of stroke.
White HD; Simes RJ; Anderson NE; Hankey GJ; Watson JD; Hunt D; Colquhoun DM; Glasziou P; MacMahon S; Kirby AC; West MJ; Tonkin AM
N Engl J Med; 2000 Aug; 343(5):317-26. PubMed ID: 10922421
[TBL] [Abstract][Full Text] [Related]
36. Net clinical benefit of warfarin therapy in elderly Chinese patients with atrial fibrillation.
Siu CW; Tse HF
Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):300-6. PubMed ID: 24610776
[TBL] [Abstract][Full Text] [Related]
37. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation.
N Engl J Med; 1991 Jul; 325(2):129-32. PubMed ID: 2052049
[No Abstract] [Full Text] [Related]
38. Warfarin in haemodialysis patients with atrial fibrillation: what benefit?
Yang F; Chou D; Schweitzer P; Hanon S
Europace; 2010 Dec; 12(12):1666-72. PubMed ID: 21045011
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation.
Pengo V; Zasso A; Barbero F; Banzato A; Nante G; Parissenti L; John N; Noventa F; Dalla Volta S
Am J Cardiol; 1998 Aug; 82(4):433-7. PubMed ID: 9723629
[TBL] [Abstract][Full Text] [Related]
40. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.
Lancet; 1994 Mar; 343(8899):687-91. PubMed ID: 7907677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
